NASD · Healthcare · Medical Distribution · USA
Henry Schein Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Distribution industry.
Henry Schein is a healthcare solutions company distributing products and services to dental and medical practitioners, including ambulatory surgery centers and other alternate care facilities. The company operates three segments: distribution and value-added services for dental and medical markets, specialty products including dental implants and orthopedic items, and practice management software and digital services.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Henry Schein Inc stock.
Slightly overvalued: intrinsic value $78.63 per share, market price $83.97, margin of safety -6.8% (as of 2026-10-19).
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $78.63; the price of $83.97 is 7% above that value, and 77% of that value comes from beyond year five.
Leak Score: 47/100 on 12 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 11 Medical Distribution stocks
HSIC is slightly overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $78.63; the price of $83.97 is 7% above that value, and 77% of that value comes from beyond year five.
$78.63 per share (as of the 2026-10-19 close), against a market price of $83.97. That is a margin of safety of -6.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
47 out of 100, which we rate "On Watch", on 12 of 12 value investing signals.